[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337474-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337474-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","long-noncoding-rna-meg3-regulates-cell-proliferation-and-apoptosis-by-disrupting-microrna-9-5p-mediated-inhibition-of-ndrg1-in-prostate-cancer","Long noncoding RNA MEG3 regulates cell proliferation and apoptosis by disrupting microRNA-9-5p-mediated inhibition of NDRG1 in prostate cancer","","Long noncoding RNA MEG3 is implicated in gene-expression control and cancer progression, yet its function in prostate cancer (PCa) remains unclear. RNA-sequencing, qRT-PCR, cellular fractionation, and fluorescent in situ hybridization were used to profile MEG3 in PCa models. Functional assays evaluated effects on proliferation and apoptosis in vitro and in vivo, while RNA immunoprecipitation verified the MEG3–miR-9-5p interaction and luciferase reporter assays assessed regulation of NDRG1 by miR-9-5p. MEG3 was downregulated in PCa and associated with biochemical recurrence.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/long-noncoding-rna-meg3-regulates-cell-proliferation-and-apoptosis-by-disrupting-microrna-9-5p-mediated-inhibition-of-ndrg1-in-prostate-cancer/337474/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/long-noncoding-rna-meg3-regulates-cell-proliferation-and-apoptosis-by-disrupting-microrna-9-5p-mediated-inhibition-of-ndrg1-in-prostate-cancer/337474.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the central role of lncRNA MEG3 in this study?","Question",{"text":63,"@type":64},"The study shows that lncRNA MEG3 inhibits prostate cancer cell proliferation and promotes apoptosis. This occurs through disrupting microRNA-9-5p-mediated inhibition of NDRG1.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were MEG3 and its related mechanisms investigated?",{"text":68,"@type":64},"Differential MEG3 expression was identified using RNA-sequencing, with qRT-PCR used for measurement. Cellular localization was assessed by fractionation and fluorescent in situ hybridization, and interactions were tested using RNA immunoprecipitation and luciferase reporter assays.",{"name":70,"@type":61,"acceptedAnswer":71},"What happens when lncMEG3 levels change in prostate cancer?",{"text":72,"@type":64},"MEG3 is downregulated in prostate cancer cells and tissues. Lower MEG3 levels correlate with biochemical recurrence, while overexpression suppresses proliferation and increases apoptosis both in vitro and in vivo.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337474,1790176749,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 2  \nResearch Paper  \nLong noncoding RNA MEG3 regulates cell proliferation and apoptosis by disrupting microRNA-9-5p-mediated inhibition of NDRG1 in prostate cancer  \nZhenpeng Lian1, Pei Tian1, Shenfei Ma2, Taihao Chang2, Ranlu Liu2, Qingchuan Feng3, Jing Li1  \n1 Department of Urology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China  \n2Tianjin Institute of Urology, Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China  \n3 Department of Medical Genetics and Cell Biology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China  \nCorrespondence to: Qingchuan Feng, Jing Li; email: [fengqingchuan@zzu.edu.cn](fengqingchuan@zzu.edu.cn); [lijing_doc@163.com](lijing_doc@163.com), [https://orcid.org/0009-0008-1301-2533](https://orcid.org/0009-0008-1301-2533)  \nKeywords: lncMEG3, miR-9-5p, NDRG1, prostate cancer  \nReceived: September 26, 2023 Accepted: December 15, 2023 Published: January 24, 2024  \nCopyright: © 2024 Lian et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nBackground: Long noncoding RNA MEG3 has been described to be involved in the regulation of gene expression and cancer progression. However, the role of lncMEG3 in prostate cancer (PCa) remains largely uncharted. Methods: Differential expression of lncMEG3 was identified in PCa tissues using RNA-sequencing analysis. qRTPCR was performed to examine the level of lncMEG3. Additionally, cellular fractionation and fluorescent in situ hybridization techniques were employed to determine the localization. Subsequently, functional assays were conducted to evaluate the impact of lncMEG3 and miR-9-5p on PCa proliferation and apoptosis in vitro and in vivo. The interaction between lncMEG3 and miR-9-5p was confirmed using RNA immunoprecipitation. Moreover, luciferase reporter assays were also utilized to investigate the relationship between miR-9-5p and NDRG1.  \nResults: We observed downregulation of lncMEG3 in PCa cells and tissues. Patients with lower levels of lncMEG3 had a higher likelihood of experiencing biochemical recurrence. Overexpression of lncMEG3 resulted in the inhibition of PCa cell proliferation and the promotion of apoptosis. Moreover, lncMEG3 is competitively bound to miR-9-5p, preventing its inhibitory effect on the target gene NDRG1 . This ultimately led to the inhibition of PCa cell proliferation and the promotion of apoptosis. Furthermore, increasing lncMEG3 levels also demonstrated inhibitory effects on PCa proliferation and promotion of apoptosis in vivo.  \nConclusions: Our findings uncover a crucial role for lncMEG3 in inhibiting PCa proliferation and promoting apoptosis through disruption of miR-9-5p-mediated inhibition of NDRG1.  \nINTRODUCTION  \nProstate cancer (PCa) is a significant global health issue, with a substantial number of new cases and fatalities annually. According to the Global Cancer Statistics 2020, there were approximately 1.4 million new cases of PCa reported worldwide. Additionally, PCa was  \nidentified as the second most prevalent form of cancer and a leading cause of cancer-related deaths in men, with approximately 375,000 fatalities attributed to this disease. The incidence rates continued to increase, especially in China and eastern Europe [1] Moreover, in East Asian countries, most patients were diagnosed at an advanced stage with lymph nodes or distant metastases  \n[2] . Although a variety of treatments and drugs have been used to treat the advanced PCa recently, overall survival remains unsatisfactory. Therefore, it is essential to clarify the underlying mechanisms of PCa progression and look for reliable biomarkers to distinguish tumors in the ","cbCaisvnJBN7oBCc","https://ap.wps.com/l/cbCaisvnJBN7oBCc","pdf",3563208,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the central role of lncRNA MEG3 in this study?\",\"answer\":\"The study shows that lncRNA MEG3 inhibits prostate cancer cell proliferation and promotes apoptosis. This occurs through disrupting microRNA-9-5p-mediated inhibition of NDRG1.\"},{\"question\":\"How were MEG3 and its related mechanisms investigated?\",\"answer\":\"Differential MEG3 expression was identified using RNA-sequencing, with qRT-PCR used for measurement. Cellular localization was assessed by fractionation and fluorescent in situ hybridization, and interactions were tested using RNA immunoprecipitation and luciferase reporter assays.\"},{\"question\":\"What happens when lncMEG3 levels change in prostate cancer?\",\"answer\":\"MEG3 is downregulated in prostate cancer cells and tissues. Lower MEG3 levels correlate with biochemical recurrence, while overexpression suppresses proliferation and increases apoptosis both in vitro and in vivo.\"}]","Long noncoding RNA MEG3 regulates cell proliferation and apoptosis by disrupting microRNA-9-5p-mediated inhibition of NDRG1 in prostate cancer | PDF",1790019270,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfc969d55b7f07fa164472dcf102bc11.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/156f9919fba7ec2dceec9ff0bc401de9.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e77a975157db6716322a4ca14be4a93.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e321d6becd5863b905d9ef393166e27.webp",980,1268]